Objective To analyze the key genes influencing the progonosis of SCI by salidroside(SAL) based on bioinformatics, and to a new targets for the treatement of SCI. Methods The targets of SAL were searched through SwissTargetPrediction, CTD, and HERB database. The differentially expressed genes in the rat SCI gene chip dataset GSE45006 were analyzed by R software. Venny 2.1 analysis was carried out to find shared genes between the SAL targets and differentially expressed genes in the GSE45006 dataset. The STRING database and Cytoscape software were utilized to identify core targets. GO functional and KEGG analyses were performed using the Metascape database to clarify the mechanisms by which SAL acts on SCI. Finally, a rat model of SCI was constructed, and the core genes were validate using real-time fluorescence quantititative polymerase chain reaction (qRT-PCR) technique. Results A total of 25 common target genes of SAL and SCI were obtained by database screening. GO enrichment analysis indicated that the intersection target genes were mainly involved in biological processes such as hypoxia response, nutrient response, positive regulation of cell development, neuronal cell body, apical part of cell, cytokine receptor binding and so on. KEGG highlighted several critical pathways, including AGE-RAGE signaling pathway in diabetic complications, lipid and atherosclerosis, Alzheimer disease, MAPK signaling pathway and MicroRNAs in cancer. The qRT-PCR experiment revealed that, compared to the Sham operation group, the SCI model group showed a significant downregulation of AKT1 and SPP1 expression, while the expression of FN1, TGFB1, CASP1, IL-18, HMOX1, MAPT, CYBB and RELA was significantly upregulated. Compared with the SCI group, the mRNA expression levels of AKT1, FN1, TGFB1, IL-18, HMOX1, MAPT, CYBB, TUBB3, and RELA decreased in the SAL group. Conversely, the mRNA expression levels of CASP1 and CASP3 increased, while the expression of SPP1 remained unchanged with no significant difference. Conclusion The FN1, TGFB1, IL-18, HMOX1, CYBB, and RELA genes are potential biomarkers for the treatment of SCI with SAL.